Update shared on 09 Dec 2025
Analysts have maintained their price target for Alkyl Amines Chemicals at ₹2,256 per share, with only marginal tweaks to the discount rate and long-term valuation inputs, reflecting continued confidence in the companys growth and profitability profile.
What's in the News
- Board meeting scheduled for November 04, 2025, to approve unaudited financial results for the quarter and half year ended September 30, 2025, and to consider a revision in remuneration (Key Developments)
- Special and extraordinary shareholders meeting to be conducted via postal ballot in India on December 20, 2025 (Key Developments)
Valuation Changes
- Fair Value: Maintained at ₹2,256 per share, indicating no change in the intrinsic value estimate.
- Discount Rate: Edged down slightly from 13.34 percent to 13.33 percent, implying a marginally lower perceived risk profile.
- Revenue Growth: Unchanged at approximately 14.40 percent, suggesting stable expectations for top line expansion.
- Net Profit Margin: Effectively flat at about 13.82 percent, reflecting no material revision in long term profitability assumptions.
- Future P/E: Trimmed marginally from 51.31x to 51.30x, indicating a virtually unchanged valuation multiple applied to forward earnings.
Have other thoughts on Alkyl Amines Chemicals?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
